These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33565785)

  • 1. An Integrated Review of Hypertrophic Cardiomyopathy in Black Populations: Underrecognized and Understudied.
    Arabadjian M; McCarthy M; Dickson VV
    J Cardiovasc Nurs; 2021 Mar-Apr 01; 36(2):104-115. PubMed ID: 33565785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease Expression and Outcomes in Black and White Adults With Hypertrophic Cardiomyopathy.
    Arabadjian ME; Yu G; Sherrid MV; Dickson VV
    J Am Heart Assoc; 2021 Sep; 10(17):e019978. PubMed ID: 34431363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current perspectives in hypertrophic cardiomyopathy with the focus on patients in the Finnish population: a review.
    Kuusisto J; Sipola P; Jääskeläinen P; Naukkarinen A
    Ann Med; 2016 Nov; 48(7):496-508. PubMed ID: 27460395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Access and Outcomes Among Hypertrophic Cardiomyopathy Patients in a Large Integrated Health System.
    Thomas A; Papoutsidakis N; Spatz E; Testani J; Soucier R; Chou J; Ahmad T; Darr U; Hu X; Li F; Chen ME; Bellumkonda L; Sumathipala A; Jacoby D
    J Am Heart Assoc; 2020 Feb; 9(3):e014095. PubMed ID: 31973610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy.
    Maron BJ; Carney KP; Lever HM; Lewis JF; Barac I; Casey SA; Sherrid MV
    J Am Coll Cardiol; 2003 Mar; 41(6):974-80. PubMed ID: 12651044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Race With Disease Expression and Clinical Outcomes Among Patients With Hypertrophic Cardiomyopathy.
    Eberly LA; Day SM; Ashley EA; Jacoby DL; Jefferies JL; Colan SD; Rossano JW; Semsarian C; Pereira AC; Olivotto I; Ingles J; Seidman CE; Channaoui N; Cirino AL; Han L; Ho CY; Lakdawala NK
    JAMA Cardiol; 2020 Jan; 5(1):83-91. PubMed ID: 31799990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sudden death related cardiomyopathies - Hypertrophic cardiomyopathy.
    Goff ZD; Calkins H
    Prog Cardiovasc Dis; 2019; 62(3):212-216. PubMed ID: 31004609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life and physical functioning in black and white adults with hypertrophic cardiomyopathy.
    Arabadjian M; Yu G; Vorderstrasse A; Sherrid MV; Dickson VV
    Heart Lung; 2022; 56():142-147. PubMed ID: 35901604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertrophic cardiomyopathy in South African Blacks.
    Lewis BS; Agathangelou NE; Flax H; Taams MA; Barlow JB
    S Afr Med J; 1983 Feb; 63(8):266-70. PubMed ID: 6681681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dilemma of genotype positive-phenotype negative hypertrophic cardiomyopathy.
    Sylvester J; Seidenberg P; Silvis M
    Curr Sports Med Rep; 2014; 13(2):94-9. PubMed ID: 24614422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort.
    Maron BJ; Casey SA; Poliac LC; Gohman TE; Almquist AK; Aeppli DM
    JAMA; 1999 Feb; 281(7):650-5. PubMed ID: 10029128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators.
    Maron BJ; Casey SA; Olivotto I; Sherrid MV; Semsarian C; Autore C; Ahmed A; Boriani G; Francia P; Winters SL; Giudici M; Koulova A; Garberich R; Rowin EJ; Sears SF; Maron MS; Spirito P
    Circ Arrhythm Electrophysiol; 2018 Apr; 11(4):e005820. PubMed ID: 29625970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of newer cardiac magnetic resonance-based risk markers for sudden death prevention in hypertrophic cardiomyopathy: An international multicenter study.
    Rowin EJ; Maron MS; Adler A; Albano AJ; Varnava AM; Spears D; Marsy D; Heitner SB; Cohen E; Leong KMW; Winters SL; Martinez MW; Koethe BC; Rakowski H; Maron BJ
    Heart Rhythm; 2022 May; 19(5):782-789. PubMed ID: 34933112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertrophic cardiomyopathy: a systematic review.
    Maron BJ
    JAMA; 2002 Mar; 287(10):1308-20. PubMed ID: 11886323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable cardioverter defibrillator therapy and sudden death risk stratification in hypertrophic cardiomyopathy patients with midventricular obstruction: A single-center experience.
    Maeda R; Minami Y; Haruki S; Kanbayashi K; Itani R; Suzuki A; Ejima K; Shiga T; Shoda M; Hagiwara N
    Int J Cardiol; 2016 Jul; 214():419-22. PubMed ID: 27088403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A missense mutation in the beta myosin heavy chain gene is a predictor of premature sudden death in patients with hypertrophic cardiomyopathy.
    Marian AJ; Kelly D; Mares A; Fitzgibbons J; Caira T; Qun-Tao ; Hill R; Perryman MB; Roberts R
    J Sports Med Phys Fitness; 1994 Mar; 34(1):1-10. PubMed ID: 7934006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertrophic Cardiomyopathy-Related Sudden Cardiac Death in Young People in Ontario.
    Weissler-Snir A; Allan K; Cunningham K; Connelly KA; Lee DS; Spears DA; Rakowski H; Dorian P
    Circulation; 2019 Nov; 140(21):1706-1716. PubMed ID: 31630535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormalities in sodium current and calcium homoeostasis as drivers of arrhythmogenesis in hypertrophic cardiomyopathy.
    Coppini R; Santini L; Olivotto I; Ackerman MJ; Cerbai E
    Cardiovasc Res; 2020 Jul; 116(9):1585-1599. PubMed ID: 32365196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.
    Maron BJ; Rowin EJ; Casey SA; Link MS; Lesser JR; Chan RH; Garberich RF; Udelson JE; Maron MS
    J Am Coll Cardiol; 2015 May; 65(18):1915-28. PubMed ID: 25953744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the new risk prediction model (HCM Risk-SCD) and classic risk factors for sudden death in patients with hypertrophic cardiomyopathy and defibrillator.
    Ruiz-Salas A; García-Pinilla JM; Cabrera-Bueno F; Fernández-Pastor J; Peña-Hernández J; Medina-Palomo C; Barrera-Cordero A; De Teresa E; Alzueta J
    Europace; 2016 May; 18(5):773-7. PubMed ID: 25855675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.